Bionest Launches executive in residence program

26 September 2004

French advisory and management firm Bionest Partners says it has launched its new Executive in Residence program, which comprises a network of highly-experienced executives who have a proven history of success in international management in the health care sector.

Managing this service gives Bionest fast access to a wide range of skills that can be utilized for a client's specific needs, such as in marketing or regulatory fields, the firm noted.

"This program is the first of its kind and has already been used by a number of clients," said Alain Gilbert, managing partner of Bionest Partners.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight